Trial Profile
A Prospective Study on Safety and Efficacy of Sofosbuvir Based Antiviral Regimen for Treating Hepatitis C in Patients With Moderate to Advanced Chronic Kidney Disease and Patients Receiving Renal Replacement Therapy
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2019
Price :
$35
*
At a glance
- Drugs Sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 01 Nov 2019 Status changed from recruiting to withdrawn prior to enrolment.
- 06 Oct 2015 New trial record